Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001437749-13-013903
Filing Date
2013-11-05
Accepted
2013-11-05 15:59:46
Documents
2
Effectiveness Date
2013-11-05

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A bota20131105_defa14a.htm DEFA14A 36869
2 bota20131105_defa14aimg001.jpg GRAPHIC 3403
  Complete submission text file 0001437749-13-013903.txt   43029
Mailing Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009
Business Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009 301-770-3099
Biota Pharmaceuticals, Inc. (Filer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEFA14A | Act: 34 | File No.: 001-35285 | Film No.: 131192568
SIC: 2836 Biological Products, (No Diagnostic Substances)